UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Neurology, ISSN 0028-3878, 02/2020, Volume 94, Issue 5, pp. e521 - e528
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Small Cell Lung Carcinoma - cerebrospinal fluid | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | ErbB Receptors - genetics | Ovarian Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - cerebrospinal fluid | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - diagnosis | Meningeal Carcinomatosis - secondary | Carcinoma - cerebrospinal fluid | Meningeal Carcinomatosis - genetics | Epithelial Cell Adhesion Molecule | Small Cell Lung Carcinoma - secondary | Gastrointestinal Neoplasms - pathology | Carcinoma, Non-Small-Cell Lung - secondary | Flow Cytometry | Sensitivity and Specificity | Carcinoma, Lobular - cerebrospinal fluid | Aged, 80 and over | Meningeal Carcinomatosis - cerebrospinal fluid | Adult | Female | Carcinoma, Ductal, Breast - cerebrospinal fluid | Carcinoma, Transitional Cell - cerebrospinal fluid | Carcinoma, Ductal, Breast - secondary | Carcinoma - secondary | Carcinoma, Lobular - secondary | Lung Neoplasms - genetics | Meningeal Carcinomatosis - diagnosis | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Transitional Cell - diagnosis | Carcinoma - diagnosis | Carcinoma, Lobular - diagnosis | Carcinoma, Ductal, Breast - diagnosis | Magnetic Resonance Imaging | Breast Neoplasms - pathology | Neoplastic Cells, Circulating | Small Cell Lung Carcinoma - diagnosis | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Nature cell biology, ISSN 1465-7392, 01/2014, Volume 16, Issue 10, pp. 982 - 991
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Carcinoma, Papillary - genetics | Butylhydroxybutylnitrosamine | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Carcinoma, Squamous Cell - chemically induced | Male | Mice, 129 Strain | Urinary Bladder Neoplasms - chemically induced | Carcinoma, Papillary - metabolism | Carcinoma in Situ - genetics | Urinary Bladder Neoplasms - genetics | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Carcinoma, Transitional Cell - chemically induced | Urinary Bladder Neoplasms - metabolism | Carcinoma, Transitional Cell - genetics | Mice, Transgenic | Carcinoma, Transitional Cell - metabolism | Keratin-5 - genetics | Carcinoma, Papillary - chemically induced | Mice, Knockout | Cell Lineage | Microscopy, Confocal | Animals | Keratin-5 - metabolism | Luminescent Proteins - genetics | Carcinoma in Situ - metabolism | Carcinoma in Situ - chemically induced | Luminescent Proteins - metabolism | Development and progression | Genetic aspects | Bladder cancer | Identification and classification | Cancer cells | Index Medicus
Journal Article
Human pathology, ISSN 0046-8177, 11/2018, Volume 81, pp. 184 - 191
Immunohistochemistry | PD-L1 | Immune checkpoint inhibitors | Transitional cell carcinoma | Urothelial carcinoma | Bladder cancer | PD-1 | Life Sciences & Biomedicine | Pathology | Science & Technology | Carcinoma, Transitional Cell - mortality | Carcinoma, Small Cell - surgery | Adenocarcinoma - pathology | Tissue Array Analysis | Carcinoma, Squamous Cell - pathology | Humans | Carcinoma, Squamous Cell - surgery | Urothelium - pathology | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Urinary Bladder Neoplasms - pathology | Urinary Bladder Neoplasms - mortality | Biomarkers, Tumor - analysis | Adenocarcinoma - immunology | Risk Factors | Carcinoma, Squamous Cell - immunology | Urinary Bladder Neoplasms - surgery | Carcinoma, Small Cell - immunology | Cystectomy | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - immunology | Urothelium - immunology | Urinary Bladder Neoplasms - immunology | B7-H1 Antigen - analysis | Carcinoma, Transitional Cell - surgery | Urothelium - surgery | Carcinoma, Small Cell - pathology | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Monoclonal antibodies | Squamous cell carcinoma | Analysis | Tumors | Studies | Immunoglobulins | Hypotheses | Medical prognosis | Immunotherapy | Clinical trials | Biomarkers | Metastasis | Cancer therapies | Immune system | Index Medicus
Journal Article
Histopathology, ISSN 0309-0167, 01/2020, Volume 76, Issue 2, pp. 191 - 200
PD‐L1 immunohistochemistry assay | head and neck carcinoma | urothelial carcinoma | assay comparison | breast carcinoma | Pathology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Immunohistochemistry | Squamous Cell Carcinoma of Head and Neck - metabolism | Tissue Array Analysis | Urinary Bladder Neoplasms - diagnosis | Humans | Squamous Cell Carcinoma of Head and Neck - pathology | Head and Neck Neoplasms - metabolism | Urothelium - pathology | Breast Neoplasms - metabolism | Urinary Bladder Neoplasms - pathology | Female | Retrospective Studies | Urinary Bladder Neoplasms - metabolism | Antibodies, Monoclonal - immunology | Carcinoma, Transitional Cell - diagnosis | Squamous Cell Carcinoma of Head and Neck - diagnosis | Pathologists | Carcinoma, Transitional Cell - metabolism | Head and Neck Neoplasms - pathology | B7-H1 Antigen - metabolism | Algorithms | B7-H1 Antigen - antagonists & inhibitors | Carcinoma, Transitional Cell - pathology | Breast Neoplasms - pathology | Head and Neck Neoplasms - diagnosis | Breast Neoplasms - diagnosis | Observer Variation | Cohort Studies | Breast carcinoma | Squamous cell carcinoma | Immunotherapy | Ligands | Head and neck cancer | Lymphocytes T | Breast cancer | Urothelial carcinoma | Tumors | Apoptosis | Index Medicus
Journal Article
JAMA oncology, ISSN 2374-2437, 08/2017, Volume 3, Issue 9, pp. e172411 - e172411
Life Sciences & Biomedicine | Oncology | Science & Technology | Abdominal Neoplasms - secondary | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Carcinoma, Transitional Cell - secondary | Antibodies, Monoclonal - therapeutic use | Male | Response Evaluation Criteria in Solid Tumors | Antineoplastic Agents - therapeutic use | Liver Neoplasms - chemistry | Abdominal Neoplasms - chemistry | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Abdominal Neoplasms - drug therapy | Liver Neoplasms - drug therapy | Survival Rate | Disease-Free Survival | Retreatment | Carcinoma, Transitional Cell - chemistry | Carcinoma, Transitional Cell - drug therapy | Aged | B7-H1 Antigen - analysis | Neoplasm Staging | Index Medicus | Online First | Online Only | Research | Original Investigation
Journal Article
The Journal of urology, ISSN 0022-5347, 2015, Volume 194, Issue 2, pp. 556 - 562
Urology | lymphocytes | tumor infiltrating | carcinoma | urinary bladder | CD8 | antigens | prognosis | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Carcinoma, Transitional Cell - mortality | Immunohistochemistry | Antigens, CD - immunology | Prognosis | Humans | Middle Aged | Male | Urinary Bladder - pathology | Antigens, CD - metabolism | Young Adult | Integrin alpha Chains - immunology | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Retrospective Studies | Urinary Bladder Neoplasms - mortality | Survival Rate - trends | Urinary Bladder - metabolism | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Proportional Hazards Models | Urinary Bladder - immunology | Integrin alpha Chains - metabolism | China - epidemiology | Disease-Free Survival | Carcinoma, Transitional Cell - pathology | Lymphocytes, Tumor-Infiltrating - pathology | Carcinoma, Transitional Cell - immunology | Adolescent | Fluorescent Antibody Technique | Urinary Bladder Neoplasms - immunology | Aged | Neoplasm Staging | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus | Abridged Index Medicus
Journal Article
Nature genetics, ISSN 1061-4036, 12/2016, Volume 48, Issue 12, pp. 1490 - 1499
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Prospective Studies | Humans | Neural Cell Adhesion Molecule L1 - genetics | Carcinoma, Transitional Cell - secondary | Mutagenesis - genetics | APOBEC-1 Deaminase - genetics | Urinary Bladder Neoplasms - drug therapy | Clonal Evolution - genetics | Mutation - genetics | Clone Cells - metabolism | Exome | Drug Resistance, Neoplasm - genetics | Clone Cells - pathology | Urinary Bladder Neoplasms - genetics | Carcinoma, Transitional Cell - drug therapy | Urinary Bladder Neoplasms - pathology | Antineoplastic Agents - pharmacology | High-Throughput Nucleotide Sequencing | Carcinoma, Transitional Cell - genetics | Studies | Medical research | Chemotherapy | Lymphatic system | Editing | Phylogenetics | Mutation | Metastasis | Patients | Tumors | Cancer | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 06/2012, Volume 18, Issue 12, pp. 3377 - 3386
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Cell Cycle - genetics | Cell Adhesion - genetics | Urinary Bladder Neoplasms - classification | Humans | Male | Mutation Rate | Gene Expression Profiling | Genetic Markers | Carcinoma, Transitional Cell - classification | Urinary Bladder Neoplasms - genetics | Carcinoma, Transitional Cell - pathology | Receptor Protein-Tyrosine Kinases - genetics | Urinary Bladder Neoplasms - pathology | Female | Biomarkers, Tumor - genetics | Keratins - genetics | Carcinoma, Transitional Cell - genetics | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
European urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 447 - 461
Urology | Cystectomy | Transurethral resection (TUR) | Prognosis | Intravesical chemotherapy | Bacillus Calmette-Guérin (BCG) | Diagnosis | Urothelial carcinoma | Bladder cancer | European Association of Urology | Guidelines | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Adjuvants, Immunologic - administration & dosage | Carcinoma in Situ - pathology | Neoplasm Invasiveness | Europe | Humans | Cystoscopy | Carcinoma, Transitional Cell - therapy | Antineoplastic Agents - administration & dosage | Carcinoma in Situ - therapy | Urinary Bladder - pathology | Societies, Medical | Carcinoma, Transitional Cell - pathology | Urinary Bladder Neoplasms - therapy | Urinary Bladder Neoplasms - pathology | Administration, Intravesical | Neoplasm Staging | Muscle, Smooth - pathology | BCG Vaccine - administration & dosage | Practice Guidelines as Topic | Medical colleges | Carcinoma | Cancer | Index Medicus
Journal Article